Literature DB >> 65445

Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.

O R Kaaden, K H Adam, K Strohmeier.   

Abstract

The specificity of guinea pig antisera against large cyanogen bromide-cleaved peptides of the virus capsid protein VP3 of foot-and-mouth disease virus type O1, strain Kaufbeuren has been characterized by double immunodiffusion, virus neutralization and protection tests. Antibodies to purified 146S particles and the cleavage peptides of VP3 showed an incomplete cross-section against VP3 peptide antigen when reacted in immunodiffusion tests, indicating that new antigenic determinants are exhibited by the peptides which are not recognized by the antiserum against the native virus proteins. The immune response against the reduced, unfolded chain constituents of VP3 was lower in comparison to that of native virus particles but still some immunological determinants remained actively capable of inducing virus-neutralizing antibodies in immunized guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65445     DOI: 10.1099/0022-1317-34-2-397

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Authors:  J V Hughes; L W Stanton; J E Tomassini; W J Long; E M Scolnick
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

4.  Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.

Authors:  A Cheung; J DeLamarter; S Weiss; H Küpper
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

5.  Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.

Authors:  M Chow; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Computer simulations to identify in polyproteins of FMDV OK1 and A12 strains putative nonapeptides with amino acid motifs for binding to BoLA class I A11 and A20 haplotype molecules.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 7.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds.

Authors:  Chenwen Xiao; Zahid Iqbal Rajput; Diwen Liu; Songhua Hu
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

9.  Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.

Authors:  B H Robertson; D M Moore; M J Grubman; D G Kleid
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

10.  Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.

Authors:  K C McCullough; R Butcher
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.